人体血液中主要的铁调节剂素-25的Cu (II) 亲和常数和反应性
Dawid Płonka1, Marta D Wiśniewska1, Joanna Ziemska-Legięcka1
1Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, Warsaw 02-106, Poland.
Journal of inorganic biochemistry
|September 9, 2023
概括
这项研究量化了铜与肝素 (H25) 的结合,揭示了一个强大,稳定的复合体. 这些发现澄清了铜的含量.
科学领域:
- 生物化学 生物化学
- 金属蛋白化学 金属蛋白化学
背景情况:
- 肝素 (H25) 是一种关键的铁调节激素,具有金属结合部位 (ATCUN/NTS).
- 之前对Cu (II) - 赫普西丁复合物的研究受限于的溶解性和处理问题.
研究的目的:
- 准确地确定在生理pH值下对肝素25- (H25) 的Cu(II) 条件结合常数.
- 描述CuH25复合物的稳定性和反应性.
主要方法:
- 利用光竞赛实验比较H25与模型.
- 在pH值7.4时确定Cu (II) 条件结合常数 (C (K (7.4)).
主要成果:
- 在pH 7.4时,Cu (II) 条件结合常数为H25被确定为4 ± 2 × 10 14 M -1.
- 由此产生的CuH25复合体在交换反应中表现出很高的惰性.
- 该综合体在甲酸盐消耗测试中表现出低反应性.
结论:
- 在生理pH值下,肝素对Cu (II) 具有非常强烈和稳定的结合亲和力.
- 复合CuH25的惰性性质表明,它在涉及铜的氧化还原反应中具有有限的直接作用.
- 需要进一步的研究,以了解Cu (II) 与肝的相互作用的生理影响.
相关概念视频
EDTA: Conditional Formation Constant
950
Each EDTA molecule has six binding sites: four carboxyl groups and two amino groups. The fully protonated form of EDTA is represented as H6Y2+. However, it can exist in different forms, H5Y+, H4Y, H3Y−, H2Y2−, and HY3−, depending on the pH of the solution. In very basic solutions with pH > 10.17, the fully deprotonated form, Y4−, is the predominant species that readily complexes with metal ions in a 1:1 ratio.
For the equilibrium reaction of the metal with the...
For the equilibrium reaction of the metal with the...
950
Complexation Equilibria: Overview
734
Complexation reactions take place when dative or coordinate covalent bonds form between metal ions and ligands. The compounds formed in these reactions are called coordination compounds. The number of bonds formed between the metal ion and the ligands is called its coordination number. Generally, most metal ions in an aqueous solution are solvated by water molecules and thus exist as aqua complexes.
The equilibrium constant of the complexation reaction is represented as the formation constant...
The equilibrium constant of the complexation reaction is represented as the formation constant...
734
Drug Distribution: Plasma Protein Binding
5.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.7K
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
144
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
144
Formation of Complex Ions
23.7K
A type of Lewis acid-base chemistry involves the formation of a complex ion (or a coordination complex) comprising a central atom, typically a transition metal cation, surrounded by ions or molecules called ligands. These ligands can be neutral molecules like H2O or NH3, or ions such as CN− or OH−. Often, the ligands act as Lewis bases, donating a pair of electrons to the central atom. These types of Lewis acid-base reactions are examples of a broad subdiscipline called coordination...
23.7K
The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K


